Sangamo Therapeutics Inc logo

Sangamo Therapeutics Inc

1
NAS:SGMO (USA)  
$ 1.13 +0.01 (+0.89%) 10:09 PM EST
At Loss
P/B:
1.49
Market Cap:
$ 200.40M
Enterprise V:
$ 103.27M
Volume:
2.93M
Avg Vol (2M):
2.42M
Also Trade In:
Volume:
2.93M
At Loss
Avg Vol (2M):
2.42M

Business Description

Description
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.
Name Current Vs Industry Vs History
Cash-To-Debt 3.78
Equity-to-Asset 0.61
Debt-to-Equity 0.26
Debt-to-EBITDA -0.4
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.53
Distress
Grey
Safe
Beneish M-Score 0.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.66
9-Day RSI 62.37
14-Day RSI 63.94
6-1 Month Momentum % -45.01
12-1 Month Momentum % -85.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.04
Quick Ratio 3.04
Cash Ratio 2.72
Days Sales Outstanding 6.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.9
Shareholder Yield % -14.47

Financials (Next Earnings Date:2024-04-26 Est.)

SGMO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SGMO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sangamo Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 201.42
EPS (TTM) ($) -1.45
Beta 0.37
Volatility % 74.41
14-Day RSI 63.94
14-Day ATR ($) 0.14889
20-Day SMA ($) 0.853615
12-1 Month Momentum % -85.69
52-Week Range ($) 0.2911 - 3.16
Shares Outstanding (Mil) 177.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sangamo Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Sangamo Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Sangamo Therapeutics Inc Frequently Asked Questions

What is Sangamo Therapeutics Inc(SGMO)'s stock price today?
The current price of SGMO is $1.13. The 52 week high of SGMO is $3.16 and 52 week low is $0.29.
When is next earnings date of Sangamo Therapeutics Inc(SGMO)?
The next earnings date of Sangamo Therapeutics Inc(SGMO) is 2024-04-26 Est..
Does Sangamo Therapeutics Inc(SGMO) pay dividends? If so, how much?
Sangamo Therapeutics Inc(SGMO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1